| |
| |
|
| Insider
Information: |
Tanner Deborah L |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
29,340 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,475,957 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,340 |
|
|
| Total
Value |
$7,475,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covance Inc |
CVD |
Corp. Executive Vice P... |
2015-02-19 |
0 |
2010-06-22 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
CEO, Covance Drug Deve... |
2016-03-11 |
19,754 |
|
0 |
Premium* |
|
|
West Pharmaceutical Services Inc |
WST |
Director |
2024-04-23 |
9,586 |
2017-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WST |
West Pharmaceutical Servi... |
Director |
• • – |
2024-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
564 |
9,586 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2023-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
616 |
9,022 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
632 |
8,406 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
577 |
7,774 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
975 |
7,180 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
4,881 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,824 |
3,309 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
|
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,483 |
1,483 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2016-03-11 |
4 |
D |
$115.49 |
$529,753 |
D/D |
(4,587) |
19,754 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug Development |
• • – |
2016-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,930 |
23,967 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
CEO, Covance Drug DevelopmentO |
• – – |
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,412 |
|
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
63,144 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2015-02-19 |
4 |
D |
$107.19 |
$2,214,038 |
D/D |
(20,656) |
42,488 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2015-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,488) |
0 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-12-17 |
4 |
D |
$102.61 |
$378,836 |
D/D |
(3,692) |
58,954 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-12-05 |
4 |
S |
$103.13 |
$1,832,645 |
D/D |
(17,770) |
62,646 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-12-05 |
4 |
OE |
$58.37 |
$1,429,030 |
D/D |
22,000 |
80,416 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,460 |
58,879 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-02-18 |
4 |
D |
$101.95 |
$47,203 |
D/D |
(463) |
58,416 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-02-07 |
4 |
S |
$98.14 |
$1,390,153 |
D/D |
(14,165) |
47,419 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2014-02-07 |
4 |
OE |
$39.80 |
$441,780 |
D/D |
11,100 |
61,584 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2013-12-17 |
4 |
D |
$84.31 |
$214,569 |
D/D |
(2,545) |
50,484 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2013-02-19 |
4 |
D |
$69.01 |
$10,490 |
D/D |
(152) |
54,229 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2013-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
54,381 |
0 |
- |
|
| CVD |
Covance Inc |
Corp. Executive Vice President |
• • – |
2012-12-18 |
4 |
D |
$58.86 |
$87,760 |
D/D |
(1,491) |
43,831 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
